Literature DB >> 102729

Activation of mouse lymphocytes by anti-immunoglobulin. II. A thymus-independent response by a mature subset of B lymphocytes.

D G Sieckmann, I Scher, R Asofsky, D E Mosier, W E Paul.   

Abstract

Mouse spleen cells can be stimulated to proliferate in vitro by purified anti-mu or anti-gamma,kappa antibodies. These responses can be obtained in cell populations bearing membrane immunoglobulin (Ig), purified by the fluorescence activated cell sorter (FACS), but they are not observed in FACS-purified Ig- cell populations. Furthermore, treatment of spleen cell populations with anti-Thy 1.2 and complement does not impair the response, nor does addition of nylon wool-purified T lymphocytes enhance it. These results indicate that B lymphocytes respond to anti-Ig and that their response does not require T cells. On the other hand, cells from athymic nude (nu/nu) mice respond slightly less well to anti-mu than do cells from heterozygous littermate (nu/+) controls; nu/nu cells are almost unresponsive to anti-gamm,kappa and addition of nylon wool-purified T cells from nu/+ controls does not restore the response. This suggests that T lymphocytes or the thymus may control the appearance of cells responsive to anti-gamma,kappa. Responsiveness of normal mice to anti-mu does not appear until 4 wk of age and does not reach maximum levels until 8 wk of age. Acquisition of full responsiveness to anti-gamma,kappa is even more delayed. This, together with the failure of mice with the CBA/N B-cell defect to respond to anti-Ig, suggests that cells stimulated to proliferate by anti-Ig are a mature subset of B cells. Depletion of adherent cells by Sephadex G-10 treatment or by treatment with carbonyl iron and exposure to a magnetic field does not diminish anti-mu or anti-gamma,kappa responses, suggesting that the responsiveness does not require the presence of macrophages. Thus, activation of B-cell proliferation by anti-Ig appears to be a T-cell independent, macrophage-independent process in which membrane Ig plays a direct role in signal generation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 102729      PMCID: PMC2185118          DOI: 10.1084/jem.148.6.1628

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  In vitro response of subpopulations of human lymphocytes. II. DNA synthesis induced by anti-immunoglobulin antibodies.

Authors:  P Gausset; G Delespesse; C Hubert; B Kennes; A Govaerts
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

2.  Stimulation of mouse lymphocytes by insoluble anti-mouse immunoglobulin.

Authors:  D C Parker
Journal:  Nature       Date:  1975-11-27       Impact factor: 49.962

Review 3.  Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction.

Authors:  G F Schreiner; E R Unanue
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

4.  Macrophage Ia antigens. I. macrophage populations differ in their expression of Ia antigens.

Authors:  C Cowing; B D Schwartz; H B Dickler
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

5.  Anti-immunoglobulin stimulation of murine lymphocytes. I. Age dependency of the proliferative response.

Authors:  H L Weiner; J W Moorhead; H N Claman
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

6.  Regulation of antibody response in vitro. IX. Induction of secondary anti-hapten IgG antibody response by anti-immunoglobulin and enhancing soluble factor.

Authors:  T Kishimoto; K Ishizaka
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

7.  X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect.

Authors:  I Scher; A D Steinberg; A K Berning; W E Paul
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

8.  X-linked B-lymphocyte defect in CBA/N mice. III. Abnormal development of B-lymphocyte populations defined by their density of surface immunoglobulin.

Authors:  I Scher; S O Sharrow; W E Paul
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

9.  B-lymphocyte heterogeneity: ontogenetic development and organ distribution of B-lymphocyte populations defined by their density of surface immunoglobulin.

Authors:  I Scher; S O Sharrow; R Wistar; R Asofsky; W E Paul
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Use of isolated immature-stage B cells to understand negative selection and tolerance induction at the molecular level.

Authors:  A Norvell; M L Birkeland; J Carman; A L Sillman; R Wechsler-Reva; J G Monroe
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

2.  A major myristylated substrate of protein kinase C and protein kinase C itself are differentially regulated during murine B- and T-lymphocyte development and activation.

Authors:  P Hornbeck; H Nakabayashi; B J Fowlkes; W E Paul; D Kligman
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

Review 3.  History of interleukin-4.

Authors:  William E Paul
Journal:  Cytokine       Date:  2015-03-23       Impact factor: 3.861

4.  Isotype profiles of anti-influenza antibodies in mice bearing the xid defect.

Authors:  M A Reale; C A Bona; J L Schulman
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

5.  Induction of proliferation and differentiation of neoplastic B cells by anti-immunoglobulin and T-cell factors.

Authors:  P C Isakson; E Puré; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

6.  Lipopolysaccharide prevents apoptosis and induces responsiveness to antigen receptor cross-linking in immature B cells.

Authors:  R J Wechsler-Reya; J G Monroe
Journal:  Immunology       Date:  1996-11       Impact factor: 7.397

7.  Specific regulation of c-myc oncogene expression in a murine B-cell lymphoma.

Authors:  J E McCormack; V H Pepe; R B Kent; M Dean; A Marshak-Rothstein; G E Sonenshein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

8.  Establishment of an inbred line of mice that express a synergistic immune defect precluding in vitro responses to type 1 and type 2 antigens, B cell mitogens, and a number of T cell-derived helper factors.

Authors:  J J Mond; G Norton; W E Paul; I Scher; F D Finkelman; S House; M Schaefer; P K Mongini; C Hansen; C Bona
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

9.  Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor.

Authors:  A Muraguchi; J L Butler; J H Kehrl; A S Fauci
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

10.  Activation of murine B lymphocytes by anti-immunoglobulin is an inductive signal leading to immunoglobulin secretion.

Authors:  D C Parker; D C Wadsworth; G B Schneider
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.